Cynapsus Therapeutics Awarded Grant from The Michael J. Fox Foundation for Clinical Examination of APL-130277
04:10 EDT 9 Aug 2012 | Bionity
Cynapsus Therapeutics Inc. announced that it has been awarded a grant of USD$947,925 from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to support clinical studies to develop APL-130277, a sublingual (oral) thin film strip reformulati..
Original Article: Cynapsus Therapeutics Awarded Grant from The Michael J. Fox Foundation for Clinical Examination of APL-130277
More From BioPortfolio on "Cynapsus Therapeutics Awarded Grant from The Michael J. Fox Foundation for Clinical Examination of APL-130277"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
